baber/WOPTO huggingface dataset:
Patent CA-2613247-A1 (CA)
Title: Prophylactic or therapeutic agent for corneal/conjunctival disease
Inventor: HIRASHIMA MASAKI
IPC: A61K9/06
Filed: 2006-06-21
Abstract: Disclosed is a novel composition for the treatment of a corneal/ conjunctival disease. A prophylactic or therapeutic agent for a corneal/conjunctival disease comprising selenoprotein P as an active ingredient, more specifically a prophylactic or therapeutic agent for a corneal/conjunctival disease such as dry eye, keratoconjunctivitis sicca, punctate superficial keratitis, corneal erosion or corneal ulcer comprising selenoprotein P as an active ingredient, particularly a prophylactic or therapeutic agent for a corneal/conjunctival disease such as dry eye, keratoconjunctivitis sicca, punctate superficial keratitis, corneal erosion or corneal ulcer accompanied by a corneal and conjunctival epithelial disorder.
Patent CA-2613526-A1 (CA)
Title: A system and method for measuring and mapping a surface relative to a reference
Inventor: FRANKE JOCHEN
IPC: G01B21/30
Filed: 2005-10-20
Abstract: A system and method for measuring the displacement of a surface relative to a base reference, as well as for mapping the displacement of the surface relative to the base reference. A laser scanner generates point cloud data in respect of a measure of the spatial orientation of a distal surface relative to a reference point to define a three-dimensional image of the surface.  Reference data is stored in respect of the spatial orientation of a base reference relative to the surface. processing means to process said point cloud data and said base reference data to determine the relative displacement of said surface with respect to said base reference. A system comprising: data processing means to obtain point cloud data defining a surface in a co ordinate system coinciding with a base reference and to generate displacement data in respect of the displacement between each point of said point cloud and a related point of said base reference; comparison means to compare the displacement data against a prescribed threshold; and display means to graphically display the result of the comparison.
Patent CA-2615466-A1 (CA)
Title: Benzofused five-membered heterocycles as inhibitors of catechol-o-methyltransferase (comt) enzyme
Inventor: TIAINEN EIJA
IPC: A61K31/343
Filed: 2006-07-17
Abstract: Compounds of formula (I), wherein R1-R4, X, Y and Z are as defined in claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors.
Patent CA-2617073-A1 (CA)
Title: Foldable goal device
Inventor: HSIAO SIMON
IPC: A63B63/04
Filed: 2007-12-27
Abstract: A foldable goal device has a hockey goal frame (10), a soccer goal frame (20), two connecting straps (30), two supporting rods (40) and a net (50). The connecting straps (30) are mounted between the hockey and soccer goal frames (10, 20) and selectively holding one of the hockey and soccer goal frames (10, 20) uprightly on the other. Each connecting strap (30) has a sleeve (31). The supporting rods (40) are rigid and are detachably mounted respectively in the sleeves (31). The net (50) is mounted on the hockey and soccer goal frames (10, 20). The supporting rods (40) are rigid and firm to securely hold the hockey and soccer goal frames (10, 20) upright with respect to each other and prevent the foldable goal device from inadvertently collapsing when a soccer ball strikes the soccer goal frame (20).
Patent CA-2619266-A1 (CA)
Inventor: AURIOL JEAN-MARC
IPC: F16B19/10
Filed: 2006-07-28
Abstract: The rivet (R) has a deformable bushing constituted of a single piece but preformed to present an end (320) in mobile and fixed parts (330, 340). The two parts are, under the action of an axial force, separated such that the part (330) moved by tensile force of a mandrel (400) is urged to be opened around the fixed part (340), where the expansion of the part (330) is produced without folding. The part (330) has a conical form (332) sliding on an outer conical form (341) of the part (340), where the forms (332, 341) form angles.
Patent CA-2619313-A1 (CA)
Inventor: LE ROY BERTRAND
IPC: G06F17/00
Filed: 2006-08-29
Abstract: In a distributed computing system including at least one server and at least one client, the server simulates and executes a client-side script that generates the initial content of a Web page. Specifically, the server simulates a client-side execution environment to run the client-side script that generates the initial content of the Web page. As a result, the initial rendering of the Web page that a server sends over to the client already contains the initial content that is usually generated on the client.
Patent CA-2619590-A1 (CA)
Inventor: TRUONG VAN HUNG
IPC: G01N30/00
Filed: 2004-04-01
Abstract: The present invention provides inhalable solution based formulations of methacholine that are stable, sterile and ready-to-use. Also provided are methods for preparing the ready-to-use methacholine formulations. The formulations are useful in methacholine challenge testing for assessment of airway hyper-responsiveness in a subject.
Patent CA-2620165-A1 (CA)
Title: Systeme et procede de facturation des telecommunications sans fil ip dans un reseau convergent
Inventor: LINKOLA JANNE P
IPC: H04W4/24
Filed: 2006-10-20
Abstract: La présente invention concerne un abonné qui communique sur un réseau de télécommunications sans fil à base d'IP via un point d'accès. Les identifiants associés au point d'accès (par ex. adresse MAC, adresse IP, FQDN...) sont stockés dans une base de données. Chaque point d'accès est mis en concordance sur une ou plusieurs zones de service, chacune étant mise en concordance avec des types de service. L'abonné possède un plan tarifaire basé sur une sélection d'un ou plusieurs types de services. Lorsqu'une connexion sans fil entre l'abonné et le réseau de télécommunications sans fil à base d'IP est établie, les identifiants du point d'accès servent à récupérer un identifiant de zone de service de la base de données. Dès réalisation de la communication, un enregistrement des détails de l'appel peut être généré, il comprend l'identifiant de la zone de service pour la communication. Le système de facturation peut ensuite récupérer les informations du plan de facturation pour déterminer un tarif approprié pour l'abonné en fonction de l'identifiant de la zone de service.
Patent CA-2623564-A1 (CA)
Inventor: WRIGHT TREMITCHELL
IPC: D06F39/08
Filed: 2008-02-28
Abstract: A substrate treating appliance utilizing a plurality of different chemistries for different cycles or different wash loads with a plurality of receptacles for receiving a plurality of cartridges containing the different chemistries. Each receptacle has one half of a lock and key connection arrangement providing a unique interconnection configuration at each receptacle, relative to the remaining receptacles, permitting only a selected type of chemistry cartridge to be accepted at a particular receptacle. A connection effected between the cartridge and the receptacle occurs by rotation of the cartridge relative to the receptacle between an insertion orientation and a locking orientation. Each receptacle is shaped to receive a cylindrical mouth wall of a particular type of chemistry cartridge. Each receptacle may also be uniquely sized, relative to the remaining receptacles, to accept only a selected type of chemistry cartridge. The plurality of receptacles may be arranged adjacent to one another with each cartridge having a configuration that prevents insertion of a cartridge into a receptacle unless every cartridge located in an adjacent receptacle is rotated to the locking orientation.
Patent CA-2624970-A1 (CA)
Inventor: SAIDI OLIVIER
IPC: G06F19/00
Filed: 2006-10-13
Abstract: L'invention concerne des méthodes et des systèmes dans lesquels des renseignements cliniques, des renseignements moléculaires et des renseignements morphométriques générés par ordinateur sont utilisés dans un modèle de prévision destiné à la prévision de l'occurrence (de la récurrence, par exemple) d'un état pathologique, tel que le cancer. Un mode de réalisation de l'invention concerne un modèle permettant de prévoir la récurrence d'un cancer de la prostate, ce modèle reposant sur des caractéristiques telles que l'état de la vésicule séminale, la marge chirurgicale, l'état des ganglions lymphatiques, l'indice de coloration des récepteurs des androgènes d'une tumeur, une mesure morphométrique des noyaux épithéliaux, et au moins une mesure morphométrique du stroma. Un autre mode de réalisation de l'invention concerne un modèle permettant de prévoir un échec clinique après une prostatectomie, ce modèle reposant sur des caractéristiques telles que le score de Gleason à la biopsie, l'état des ganglions lymphatiques, le score de Gleason sur une prostatectomie, une mesure morphométrique du cytoplasme de l'épithélium, une mesure morphométrique des noyaux épithéliaux, une mesure morphométrique du stroma, et l'intensité des récepteurs des androgènes dans des cellules épithéliales racémase-positives (AMACR).
Patent CA-2627452-A1 (CA)
Inventor: GORE DHANANJAY ASHOK
IPC: H04Q7/38
Filed: 2006-10-27
Abstract: A shared signaling channel can be used in an Orthogonal Frequency Division Multiple Access (OFDMA) communication system to provide signaling, acknowledgement, and power control messages to access terminals within the system. The shared signaling channel can be assigned to a predetermined number of sub-carriers within any frame. The assignment of a predetermined number of sub-carriers to the shared signaling channel establishes a fixed bandwidth overhead for the channel. The actual sub-carriers assigned to the channel can be varied periodically, and can vary according to a predetermined frequency hopping schedule. The amount of signal power allocated to the signaling channel can vary on a per symbol basis depending on the power requirements of the communication link. The shared signaling channel can direct each message carried on the channel to one or more access terminals. Unicast messages allow the channel power to be controlled per the needs of individual communication links.
Patent CA-2627891-A1 (CA)
Title: Uses of anti-cd40 antibodies
Inventor: LUQMAN MOHAMMAD
IPC: A61K39/395
Filed: 2006-11-01
Abstract: Methods for treating a human patient for an inflammatory or autoimmune disease that is associated with CD40-expressing cells are provided, where the human patient is heterozygous or homozygous for Fc.gamma.RIIIa-158F (genotype V/F or F/F). Also provided are methods of inhibiting antibody production by B cells in a human patient who is heterozygous or homozygous for Fc.gamma.RIIIa-158F  (genotype V/F or F/F). The methods comprise administering to the human patient a therapeutically or prophylactically effective amount of an anti-CD40 antibody. Methods and kits for identifying a human patient with an inflammatory or autoimmune disease that is treatable with an anti-CD40 antibody and which is non-responsive or refractory to treatment with rituximab (Rituxan~), as well as methods and kits for selecting an antibody therapy for treatment of a human patient having an inflammatory or autoimmune disease that is non-responsive or refractory to treatment with rituximab (Rituxan~), are also provided. The methods of the present invention find use in treatment of inflammatory diseases and autoimmune diseases that are associated with CD40-expressing cells. These methods are particularly advantageous with respect to inflammatory diseases and autoimmune diseases that are associated with cells expressing both CD40 and CD20, as the methods enable the treatment of patients having an inflammatory or autoimmune disease that is non-responsive or refractory to therapy with other therapeutic agents such as anti-CD20 antibodies.
Patent CA-2627974-A1 (CA)
Inventor: POSTLETHWAITE ARNOLD E
IPC: A61K35/12
Filed: 2006-11-16
Abstract: The present invention has demonstrated for the first time that orally administered type I collagen (CI) induced tolerance to CI in patients suffering from systemic sclerosis (SSc) and ameliorated clinical manifestations of the disease. Accordingly, the present invention provides methods of treating a fibrosing disease by oral administration of a tissue protein, for example, collagen, derived from the tissue undergoing fibrosis.
Patent CA-2630193-A1 (CA)
Inventor: GROSS DOROTHEA
IPC: A61K9/00
Filed: 2006-11-17
Abstract: The invention relates to a pharmaceutical composition that is free from dexpanthenol, calcium ions, and phosphate and comprises at least one calcium chelating agent, at least one ophthalmologically compatible viscosity regulator, and one or several optional pharmaceutical adjuvants. The invention further relates to the use of a calcium chelating agent and an ophthalmologically compatible viscosity regulator for producing a phosphate-free pharmaceutical composition used for the treatment and/or prevention of epithelial defects.
Patent CA-2630824-A1 (CA)
Inventor: TANAKA HIROYUKI
IPC: C08L63/00
Filed: 2007-09-05
Abstract: Provided is a technology of suppressing semiconductor breakage due to a temperature change. For flip chip mounting a silicon chip on a build-up multilayer substrate employing a structure having a thinned core material, the core material having a small linear expansion coefficient is used for the multilayer substrate, the linear expansion coefficient of an underfill material and a glass transition point are suitably designed, corresponding to the thickness and the linear expansion coefficient of the core material. Thus, a stress inside a semiconductor package generated by deformation or the like of the multilayer substrate due to the temperature change is modified, and breakage of the semiconductor package due to the temperature change is suppressed.
Patent CA-2631098-A1 (CA)
Title: Message broadcasting admission control system and method
Inventor: WOOD MARK ANDREW
IPC: H04W4/90
Filed: 2006-11-20
Abstract: A system and method of admission control for authorizing a submission of a broadcast message to a broadcast target area includes receiving a broadcast message record including the broadcast message and the broadcast target area for the broadcast message and validating the authority of a broadcast message originator originating the broadcast message record as a function of a broadcast message originator parameter. The method also includes identifying a broadcast transmission network providing broadcast message transmission to broadcast message receiving devices located within the broadcast target area and validating the broadcast transmission network against a broadcast transmission network parameter. The method further includes forwarding the broadcast message record to an output interface associated with the broadcast transmission network for transmission to the broadcast message receiving devices within the broadcast target area.
Patent CA-2631784-A1 (CA)
Inventor: HOWARD CAROL P
IPC: A61K47/48
Filed: 2006-11-29
Abstract: The present invention is directed to metal chelating conjugates for use as metallopharmaceutical diagnostics or therapeutic agents. Specifically, conjugates of the present invention include a carrier, a metal coordinating moiety, and a urea linkage chemically linking the metal coordinating moiety to the carrier. The carrier is generally utilized for targeting the conjugate to a biological tissue or organ.
Patent CA-2632047-A1 (CA)
Title: Information reproducing device and method, and computer program
Inventor: TAKAKUWA NOBUYUKI
IPC: H04N5/91
Filed: 2006-11-22
Abstract: An information reproduction device (200) comprises display means (353) for displaying a main image and a sub-image of a first type, the display of which can be started at a desired reproduction time, storage means (355, 360) for storing the identification number of the sub-image, first control means (354, 359) for discarding the identification number of the sub-image in case the current reproduction time of the main image exceeds the range of the reproduction time, at which the sub-image is to be displayed, and second control means (354, 359) for continuously storing the identification number of the sub-image in case the current reproduction time of the main image does not exceed the range of the reproduction time, at which the sub-image is to be displayed.
Patent CA-2632185-A1 (CA)
Title: Wound exudate removal and isolation system
Inventor: KELCH RANDY
IPC: A61F13/00
Filed: 2006-12-06
Abstract: A wound exudate removal and isolation system includes a porous dressing, a canister in fluid communication with the dressing, and a first valve positioned between the dressing and the canister. The first valve is positionable between an open position and a closed position. A disposal line is fluidly connected to the canister and includes a second valve that is positionable between an open position and a closed position. A pump is fluidly connected to the canister and is configured to draw wound exudate from the dressing into the canister when the first valve is open and the second valve is closed. The pump is configured to force wound exudate from the canister into the disposal line when the first valve is closed and the second valve is open.
Patent CA-2632590-A1 (CA)
Title: Method to verify the integrity of components on a trusted platform using integrity database services
Inventor: HARDJONO THOMAS PARASU
IPC: G06F21/57
Filed: 2006-12-08
Abstract: A client platform can be verified prior to being granted access to a resource or service on a network by validating individual hardware and software components of the client platform. Digests are generated for the components of the client platform. The digests can be collected into an integrity report. An authenticator entity receives the integrity report and compares the digests with digests stored in either a local signature database, a global signature database in an integrity authority, or both. Alternatively, the digests can be collected and stored on a portable digest-collector dongle. Once digests are either validated or invalidated, an overall integrity /trust score can be generated. The overall integrity/trust score can be used to determine whether the client platform should be granted access to the resource on the network using a policy.
Patent CA-2635238-A1 (CA)
Title: Improvements in and relating to imaging of biological samples
Inventor: COURTNEY PATRICK
IPC: G01N21/64
Filed: 2007-01-19
Abstract: Methods and apparatus relating to the imaging of biological samples are provided. More particularly, they relate to the detection of light emanating from fluorescent species present in a sample in order to study the structure and dynamics of such a sample. Such a method of analysis comprises irradiating the sample with a pulse of excitation energy causing fluorescent species in the sample to fluoresce; detecting light emanating from the sample during a predetermined period of time after the pulse; generating and storing data recording at least the wavelength of the detected light against time; and analysing the data with reference to the respective lifetimes of the fluorescent species to detect the presence of the respective emissions from three or more different fluorescent species which emit light simultaneously during at least part of said predetermined period, which are indistinguishable from each other on the basis of their wavelength or lifetime alone.
Patent CA-2636623-A1 (CA)
Inventor: HOFFMAN LESLIE
IPC: A61M16/00
Filed: 2007-01-05
Abstract: A user interface for a portable continuous positive airway pressure (CPAP) device comprises a gas delivery member releasably mountable to a manifold member. The CPAP device comprises a motor blower unit contained in a wearable vest which is connectable by a patient hose to the user interface. Alternative embodiments of the gas delivery member include a nasal mask or a pair of nasal prongs which are interchangeably mountable to the manifold member. Ball joints on opposing ends of the patient hose swivelably interconnect the patient hose to the user interface and to the motor blower unit. Cheek pads extend from opposing ends of the manifold member and are freely orientatable relative thereto. Six-way adjustable head gear stabilizes the user interface on the patient's face and comprises side straps and head straps which are pivotably joined to one another and which are adjustable lengthwise to fit a wide range of patients.
Patent CA-2637396-A1 (CA)
Inventor: FAWORKA RUDOLF
IPC: A41D13/00
Filed: 2007-01-18
Abstract: The invention relates to an arrangement for cooling the body of individuals (1) or the like, having cooling elements (2) which are connected to one another in a movable manner, contain a cooling liquid (3) and are arranged in the form of a cape or shawl (4) which can be worn by the individual (1) or the like who is to be cooled. In order to create such a cooling arrangement, which allows particularly rapid and efficient cooling of individuals (1) or the like, provision is made for the cooling elements (2) to contain within them a material, for example graphite, which is a good thermal conductor in relation to the cooling liquid (3) and is intended for absorbing the cooling liquid (3).
Patent CA-2638970-A1 (CA)
Inventor: AHMAD NAWAZ
IPC: A61K31/417
Filed: 2008-08-20
Abstract: The invention relates to an anhydrous composition comprising a vasodilator and an acceptable carrier wherein the vasodilator is present in an amount effective to increase the blood flow when the composition is applied to human tissue. The compositions according to the invention are non-flushing.
Patent CA-2645281-A1 (CA)
Inventor: YOKOYAMA TORU
IPC: A61P43/00
Filed: 2007-03-28
Abstract: Disclosed is a triglyceride-lowering agent or hyperinsulinism-ameliorating agent having an excellent triglyceride-lowering activity. The triglyceride-lowering agent or hyperinsulinism-ameliorating agent comprises a pitavastatin and amlodipine or a salt thereof.
Patent CA-2645495-A1 (CA)
Title: Methode et appareil servant a attribuer une bonification sur un reseau de dispositifs de jeux electroniques pendant une periode predeterminee
Inventor: SCHNEIDER RICHARD J
IPC: G07F17/32
Filed: 2007-03-23
Abstract: Dans des modes de réalisation, l'invention concerne un système de bonus basé sur le temps qui peut être préconfiguré afin d'attribuer une certaine somme d'argent à des joueurs de dispositifs de jeu en réseau sur une certaine durée. Le système de bonus basé sur le temps peut comprendre une variété de dispositifs de jeu en réseau et un procédé de gestion de participation de sorte que chaque dispositif de la variété de dispositifs de jeu présente une représentation appropriée dans la réserve de bonus. La somme d'argent de bonus dans une réserve de bonus est prédéterminée par un casino ou autre opérateur de réseau de jeu. De plus, la somme totale d'argent de bonus dans une réserve de bonus particulière peut être divisée en multiples bonus plus petits, lesquels peuvent être distribués à de nombreux joueurs sur la durée pendant laquelle la réserve de bonus est active.
Patent CA-2648909-A1 (CA)
Title: Coatings, coating formulations, and compositions containing quaternary ammonium compounds
Inventor: SAUER JOE D
IPC: C08L101/00
Filed: 2007-04-23
Abstract: The present invention relates to compositions, coatings, coating formulations, etc., containing quaternary ammonium compounds and their use.
Patent CA-2651433-A1 (CA)
Inventor: MARZE HENRI-JAMES
IPC: B64C27/82
Filed: 2009-01-29
Abstract: La présente invention concerne un procédé de minimisation du bruit émis par un dispositif anti-couple à rotor arrière caréné à une fréquence FE et perçu à une fréquence FP selon lequel on détermine le diamètre D, le nombre de pales b et la vitesse tangentielle U de ce rotor de sorte que la fréquence perçue FP soit inférieure ou égale à la fréquence limite inférieure FL d'un tiers d'octave de fréquences prédéterminé et centré sur une fréquence FC.